RAD51D Gene Breast-Ovarian Cancer Familial Susceptibility to Type 4 Genetic Test sale cost 4400 AED
PTCH2 Gene Basal Cell Nevus Syndrome Due to Germline PTCH2 Mutation Genetic Test sale cost 4400 AED PTCH2 Gene Basal Cell Nevus Syndrome Due to Germline PTCH2 Mutation Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
MSH6 Gene Colorectal Cancer Hereditary Nonpolyposis Type 5 Genetic Test sale cost 4400 AED MSH6 Gene Colorectal Cancer Hereditary Nonpolyposis Type 5 Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

RAD51D Gene Breast-Ovarian Cancer Familial Susceptibility to Type 4 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “RAD51D Gene Breast-Ovarian Cancer Familial Susceptibility to Type 4 Genetic Test” is a specialized diagnostic tool designed to identify mutations in the RAD51D gene, which are linked to an increased risk of developing familial breast and ovarian cancer. This genetic testing is crucial for individuals with a family history of these cancers, as it helps in early detection and management of the condition. The test is conducted by DNA Labs UAE, a reputable facility known for its advanced genetic testing services. The cost of the test is 4400 AED, an investment in personal health that provides invaluable information for the management and potential prevention of cancer in at-risk individuals. By identifying the presence of specific genetic mutations, individuals can make informed decisions about their health, including taking preventative measures or undergoing more frequent screenings to catch any signs of cancer at an early, more treatable stage.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

RAD51D Gene Breast-Ovarian Cancer Familial Susceptibility to Type 4 Genetic Test

At DNA Labs UAE, we offer the RAD51D Gene Breast-Ovarian Cancer Familial Susceptibility to Type 4 Genetic Test. This specific genetic test uses Next-Generation Sequencing (NGS) technology to analyze the RAD51D gene for mutations or variations.

Test Components

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Cancer
  • Doctor: Oncologist
  • Test Department: Genetics

Pre Test Information

Prior to undergoing the RAD51D Gene Breast-Ovarian Cancer Familial Susceptibility to Type 4 Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected by RAD51D Gene Breast-Ovarian Cancer Familial Susceptibility to Type 4 NGS Genetic DNA Test gene RAD51D.

Test Details

The RAD51D Gene Breast-Ovarian Cancer Familial Susceptibility to Type 4 Genetic Test is used to determine an individual’s susceptibility to developing breast and ovarian cancer, particularly in families with a history of these cancers. The RAD51D gene is responsible for repairing damaged DNA and maintaining the stability of the genome. Mutations in this gene can impair its function, leading to an increased risk of developing breast and ovarian cancer.

NGS technology allows for the analysis of multiple genes simultaneously, providing a comprehensive assessment of genetic variations that may contribute to cancer susceptibility. By identifying mutations or variations in the RAD51D gene, this test can help individuals and their healthcare providers make informed decisions about cancer prevention, screening, and treatment options.

It is important to note that a positive result from this genetic test does not guarantee the development of breast or ovarian cancer. However, it indicates an increased risk, and individuals with positive results may benefit from enhanced surveillance and preventative measures.

It is recommended that individuals considering this test consult with a healthcare professional or genetic counselor to discuss the potential benefits, limitations, and implications of the test results.

Test Name RAD51D Gene Breast-ovarian cancer familial susceptibility to type 4 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Cancer
Doctor Oncologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for RAD51D Gene Breast-ovarian cancer, familial, susceptibility to, type 4 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with RAD51D Gene Breast-ovarian cancer, familial, susceptibility to, type 4 NGS Genetic DNA Test gene RAD51D
Test Details

RAD51D Gene Breast-ovarian cancer, familial, susceptibility to, type 4 is a specific genetic test that uses Next-Generation Sequencing (NGS) technology to analyze the RAD51D gene for mutations or variations. This test is used to determine an individual’s susceptibility to developing breast and ovarian cancer, particularly in families with a history of these cancers.

The RAD51D gene is involved in repairing damaged DNA and maintaining the stability of the genome. Mutations in this gene can impair its function, leading to an increased risk of developing breast and ovarian cancer.

NGS technology allows for the analysis of multiple genes simultaneously, providing a comprehensive assessment of genetic variations that may contribute to cancer susceptibility. By identifying mutations or variations in the RAD51D gene, this test can help individuals and their healthcare providers make informed decisions about cancer prevention, screening, and treatment options.

It is important to note that a positive result from this genetic test does not guarantee the development of breast or ovarian cancer. However, it indicates an increased risk, and individuals with positive results may benefit from enhanced surveillance and preventative measures.

It is recommended that individuals considering this test consult with a healthcare professional or genetic counselor to discuss the potential benefits, limitations, and implications of the test results.

SKU: TEST-4462 Category:

Related products